Forward Industries, Inc. 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ Commission file number 001-34780 FORWARD INDUSTRIES, INC. (Exact name of registrant as specified in its charter) New York 13-1950672 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 700 Veterans Memorial Highway , Suite 100 , Hauppauge , NY 11788 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (631) 547-3041 Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 FORD The Nasdaq Stock Market (The Nasdaq Capital Market) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 10,031,185 shares as of July 31, 2021. FORWARD INDUSTRIES, INC. AND SUBSIDIARIES PART I. FINANCIAL INFORMATION Page No. Item 1. Financial Statements Condensed Consolidated Balance Sheets at June 30, 2021 (Unaudited) and September 30, 2020 2 Condensed Consolidated Statements of Operations (Unaudited) for the Three and Nine Months Ended June 30, 2021 and 2020 3 Condensed Consolidated Statements of Shareholders' Equity (Unaudited) for the Three and Nine Months Ended June 30, 2021 and 2020 4 Condensed Consolidated Statements of Cash Flows (Unaudited) for the Nine Months Ended June 30, 2021 and 2020 5 Notes to Condensed Consolidated Financial Statements 6 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 21 Item 3. Quantitative and Qualitative Disclosures About Market Risk 33 Item 4. Controls and Procedures 33 PART II. OTHER INFORMATION Item 1. Legal Proceedings 34 Item 1A. Risk Factors 34 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 35 Item 3. Defaults Upon Senior Securities 35 Item 4. Mine Safety Disclosures 35 Item 5. Other Information 35 Item 6. Exhibits 35 Signatures 36 1 PART I. FINANCIAL INFORMATION ITEM 1. FINANCIAL STATEMENTS FORWARD INDUSTRIES, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS June 30, September 30, 2021 2020 Assets (Unaudited) Current assets: Cash $ 1,604,649 $ 2,924,627 Accounts receivable, net 7,683,659 7,602,316 Inventories 1,907,137 1,275,694 Prepaid expenses and other current assets 500,893 419,472 Total current assets 11,696,338 12,222,109 Property and equipment, net 183,740 215,323 Intangible assets, net 1,371,847 1,531,415 Goodwill 1,758,682 1,758,682 Operating lease right of use assets, net 3,848,462 3,512,042 Other assets 72,251 116,697 Total assets $ 18,931,320 $ 19,356,268 Liabilities and shareholders' equity Current liabilities: Line of credit $ – $ 1,000,000 Current portion of note payable to Forward China – 1,600,000 Accounts payable 234,644 197,022 Due to Forward China 4,439,838 3,622,401 Deferred income 444,445 485,078 Current portion of notes payable 29,159 983,395 Current portion of finance lease liability 4,050 18,411 Current portion of earnout consideration – 45,000 Current portion of operating lease liability 348,914 259,658 Accrued expenses and other current liabilities 624,328 615,401 Total current liabilities 6,125,378 8,826,366 Other liabilities: Note payable to Forward China, less current portion 1,600,000 – Notes payable, less current portion – 529,973 Operating lease liability, less current portion 3,644,688 3,359,088 Finance lease liability, less current portion – 12,769 Earnout consideration, less current portion 70,000 45,000 Total other liabilities 5,314,688 3,946,830 Total liabilities 11,440,066 12,773,196 Commitments and contingencies – – Shareholders' equity: Common stock, par value $ 0.01 per share; 40,000,000 shares authorized; 10,031,185 and 9,883,851 shares issued and outstanding at June 30, 2021 and September 30, 2020, respectively 100,312 98,838 Additional paid-in capital 19,878,497 19,579,684 Accumulated deficit ( 12,487,555 ) ( 13,095,450 ) Total shareholders' equity 7,491,254 6,583,072 Total liabilities and shareholders' equity $ 18,931,320 $ 19,356,268 The accompanying notes are an integral part of the unaudited condensed consolidated financial statements. 2 FORWARD INDUSTRIES, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) For the Three Months Ended June 30, For the Nine Months Ended June 30, 2021 2020 2021 2020 Revenues, net $ 9,964,514 $ 9,548,732 $ 28,077,496 $ 25,872,963 Cost of sales 7,781,485 7,773,944 21,888,135 20,925,017 Gross profit 2,183,029 1,774,788 6,189,361 4,947,946 Sales and marketing expenses 620,737 464,247 1,802,134 1,478,880 General and administrative expenses 1,293,941 1,485,447 5,102,545 4,324,798 Goodwill impairment – – – 1,015,000 Income/(loss) from operations 268,351 ( 174,906 ) ( 715,318 ) ( 1,870,732 ) Gain on forgiveness of note payable – – ( 1,356,570 ) – Fair value adjustment of earnout consideration 10,000 – ( 20,000 ) ( 350,000 ) Fair value adjustment of deferred cash consideration – 3,000 – 12,000 Interest income ( 32,459 ) – ( 88,760 ) – Interest expense 45,802 37,148 138,908 132,275 Other expense, net 1,421 148 3,209 3,466 Income/(loss) before income taxes 243,587 ( 215,202 ) 607,895 ( 1,668,473 ) Provision for/(benefit from) income taxes – – – – Net income/(loss) $ 243,587 $ ( 215,202 ) $ 607,895 $ ( 1,668,473 ) Earnings/(loss) per share: Basic $ 0.02 $ ( 0.02 ) $ 0.06 $ ( 0.18 ) Diluted $ 0.02 $ ( 0.02 ) $ 0.06 $ ( 0.18 ) Weighted average common shares outstanding: Basic 9,963,969 9,534,407 9,919,579 9,534,034 Diluted 10,512,893 9,534,407 10,423,108 9,534,034 The accompanying notes are an integral part of the unaudited condensed consolidated financial statements. 3 FORWARD INDUSTRIES, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) For the Three and Nine Months Ended June 30, 2021 Additional Common Stock Paid-In Accumulated Shares Amount Capital Deficit Total Balance at September 30, 2020 9,883,851 $ 98,838 $ 19,579,684 $ ( 13,095,450 ) $ 6,583,072 Share-based compensation – – 41,457 – 41,457 Stock options exercised 2,500 25 1,650 – 1,675 Net income – – – 1,199,036 1,199,036 Balance at December 31, 2020 9,886,351 98,863 19,622,791 ( 11,896,414 ) 7,825,240 Share-based compensation – – 21,287 – 21,287 Stock options exercised 66,415 665 141,858 – 142,523 Net loss – – – ( 834,728 ) ( 834,728 ) Balance at March 31, 2021 9,952,766 99,528 19,785,936 ( 12,731,142 ) 7,154,322 Share-based compensation – – 3,732 – 3,732 Stock options exercised 78,419 784 88,829 – 89,613 Net income – – – 243,587 243,587 Balance at June 30, 2021 10,031,185 $ 100,312 $ 19,878,497 $ ( 12,487,555 ) $ 7,491,254 For the Three and Nine Months Ended June 30, 2020 Additional Common Stock Paid-In Accumulated Shares Amount Capital Deficit Total Balance at September 30, 2019 9,533,851 $ 95,338 $ 18,936,130 $ ( 11,320,169 ) $ 7,711,299 Share-based compensation – – 33,179 – 33,179 Net loss – – – ( 81,657 ) ( 81,657 ) Balance at December 31, 2019 9,533,851 95,338 18,969,309 ( 11,401,826 ) 7,662,821 Share-based compensation – – 36,260 – 36,260 Net loss – – – ( 1,371,614 ) ( 1,371,614 ) Balance at March 31, 2020 9,533,851 95,338 19,005,569 ( 12,773,440 ) 6,327,467 Share-based compensation – – 37,678 – 37,678 Stock options exercised 50,000 500 31,500 – 32,000 Net loss – – – ( 215,202 ) ( 215,202 ) Balance at June 30, 2020 9,583,851 $ 95,838 $ 19,074,747 $ ( 12,988,642 ) $ 6,181,943 The accompanying notes are an integral part of the unaudited condensed consolidated financial statements. 4 FORWARD INDUSTRIES, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) For the Nine Months Ended June 30, 2021 2020 Operating Activities: Net income/(loss) $ 607,895 $ ( 1,668,473 ) Adjustments to reconcile net income/(loss) to net cash used in operating activities: Share-based compensation 66,476 107,117 Depreciation and amortization 252,317 201,778 Bad debt expense/(recovery) 513,691 ( 121,431 ) Gain on forgiveness of note payable ( 1,356,570 ) – Change in fair value of earn-out consideration ( 20,000 ) ( 350,000 ) Change in fair value of deferred cash consideration – 12,000 Goodwill impairment – 1,015,000 Impairment of investment – 326,941 Changes in operating assets and liabilities: Accounts receivable ( 595,034 ) ( 1,448,384 ) Inventories ( 631,443 ) 881,408 Prepaid expenses and other current assets ( 81,421 ) ( 61,391 ) Other assets 44,446 117,006 Accounts payable and due to Forward China 855,059 ( 55,165 ) Deferred income ( 40,633 ) 305,932 Net changes in operating lease liabilities 38,437 27,303 Accrued expenses and other current liabilities 8,926 ( 49,608 ) Net cash used in operating activities ( 337,854 ) ( 759,967 ) Investing Activities: Purchases of property and equipment ( 61,166 ) ( 55,738 ) Net cash used in investing activities ( 61,166 ) ( 55,738 ) Financing Activities: Proceeds from line of credit borrowings 150,000 900,000 Repayment of line of credit borrowings ( 1,150,000 ) ( 1,200,000 ) Repayment of notes payable ( 127,639 ) ( 54,799 ) Proceeds from note payable – 1,356,570 Proceeds from stock options exercised 233,811 32,000 Repayments of finance leases ( 27,130 ) ( 26,244 ) Payment of deferred cash consideration – ( 200,000 ) Net cash (used in)/provided by financing activities  ( 920,958 ) 807,527 Net decrease in cash ( 1,319,978 ) ( 8,178 ) Cash at beginning of period 2,924,627 3,092,813 Cash at end of period $ 1,604,649 $ 3,084,635 Supplemental Disclosures of Cash Flow Information: Cash paid for interest $ 121,771 $ 126,791 Cash paid for taxes $ 7,336 $ 1,524 Supplemental Disclosures of Non-Cash Information: Lease assets exchanged for lease liabilities $ 565,590 $ – Lease assets recorded upon adoption of ASC 842 $ – $ 3,648,582 Lease liabilities recorded upon adoption of ASC 842 $ – $ 3,729,341 The accompanying notes are an integral part of the unaudited condensed consolidated financial statements. 5 FORWARD INDUSTRIES, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS NOTE 1 OVERVIEW Business Forward Industries, Inc. (“Forward”, “we” or the “Company”) is a fully integrated design, development and manufacturing solution provider for top tier medical and technology customers worldwide. As a result of the continued expansion of our design and development capabilities through our wholly-owned subsidiaries, we are now able to introduce proprietary products to the market from concepts brought to us from a number of different sources, both inside and outside the Company. Impact of COVID-19 The outbreak of the COVID-19 virus continues to impact our results of operations. While the most significant impact was realized in Fiscal 2020, the virus continued to impact our results of operations in Fiscal 2021. The business shutdowns resulting from the pandemic disrupted our supply chain and the manufacture or shipment of our products and delayed the rollout of our retail products. Additionally, demand for our design and development services was reduced or delayed as a result of the pandemic as certain customers reduced discretionary spending. While revenues for the three and nine months ended June 30, 2021 increased as compared to the three and nine months ended June 30, 2020, they were lower than anticipated due in part to the impact of COVID-19 and the resulting economic conditions. The impact of lower than anticipated revenue was further complicated by a significant increase in freight costs due to the global shipping container shortage caused in part by the pandemic. These challenges were partially offset by a reduction in certain selling and travel related expenses. Many government restrictions have been relaxed and the economy has continued to open in more jurisdictions. However, the emergence of new and transmittable variants of COVID-19 could lead to a possible resurgence of the virus, particularly in populations with low vaccination rates and has resulted in new restrictions in certain geographies and among certain businesses. The long-term financial impact on our business cannot be reasonably estimated at this time. As a result, the effects of COVID-19 may not be fully reflected in our financial results until future periods. Refer to “Part II, Item 1A — Risk Factors” for a description of the material risks that the Company currently faces in connection with COVID-19. Until the pandemic is fully controlled, we expect business conditions to remain challenging. In response to these challenges, we will continue to focus on those factors that we can control: closely managing and controlling our expenses; aligning our design and development schedules with demand in a proactive manner as there are changes in market conditions to minimize our cash operating costs; pursuing further improvements in the productivity and effectiveness of our development, selling and administrative activities and, where appropriate, taking advantage of opportunities to enhance our business growth and strategy. To help mitigate the impact of these challenging business conditions, we implemented cost-cutting initiatives and reduced executive pay and Board of Directors compensation for the three months ended June 30, 2021. See “Liquidity and Capital Resources” section of Item 2. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for further description of these cost-cutting measures. NOTE 2 ACCOUNTING POLICIES Basis of Presentation The accompanying condensed consolidated financial statements include the accounts of Forward Industries, Inc. and all of its subsidiaries: Forward Industries (IN), Inc. (“Forward US”), Forward Industries (Switzerland) GmbH (“Forward Switzerland”), Forward Industries UK Limited (“Forward UK”), Intelligent Product Solutions, Inc. (“IPS”) and Kablooe, Inc. (“Kablooe”). The terms “Forward”, “we” or the “Company” as used throughout this document are used to indicate Forward Industries, Inc. and all of its subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation. 6 FORWARD INDUSTRIES, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS The acquisition of Kablooe took place in August 2020 and its results of operations have been included in our condensed consolidated financial statements since the acquisition date. Accordingly, our results of operations for the three and nine months ended June 30, 2021 include Kablooe’s results of operations, while our results of operations for the three and nine months ended June 30, 2020 do not. Key terms of the acquisition are contained in our Form 10-K filed with the Securities and Exchange Commission on December 17, 2020. In the opinion of management, the accompanying condensed consolidated financial statements presented in this Quarterly Report on Form 10-Q reflect all normal recurring adjustments necessary to present fairly the financial position and results of operations and cash flows for the interim periods presented herein, but are not necessarily indicative of the results of operations for the year ending September 30, 2021. These condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in its Annual Report on Form 10-K for the fiscal year ended September 30, 2020, and with the disclosures and risk factors presented therein. The September 30, 2020 condensed consolidated balance sheet has been derived from the audited consolidated financial statements. For the nine months ended June 30, 2021, the Company generated net income of $608,000, which includes $ 1,357,000 of forgiveness of note payable (see Note 12), and used $338,000 of cash flows in operating activities. The Company has an accumulated deficit of $12,488,000 at June 30, 2021. We believe our existing cash balance and working capital will be sufficient to meet our liquidity needs through at least September 30, 2022. Our largest vendor is Forward China, a related entity, which is able to extend payment terms on outstanding liabilities when necessary (see Note 9). We can provide no assurances that any such extension will be given if requested. Accounting Estimates The preparation of the Company’s condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates and assumptions. Throughout this document, certain dollar amounts and percentages have been rounded to their approximate values. Revenue Recognition Distribution Segment The Company generally recognizes revenue in its distribution segment when: (i) finished goods are shipped to our customers (in general, these conditions occur at either point of shipment or point of destination, depending on the terms of sale, i.e., transfer of control); (ii) there are no other deliverables or performance obligations; and (iii) there are no further obligations to the customer after title to the goods has transferred. When the Company receives consideration before achieving the criteria previously mentioned, it records a contract liability, which is classified as a component of deferred income in the accompanying condensed consolidated balance sheets. The distribution segment had contract liabilities of $ 139,000 , $ 75,000 and $ 0 at June 30, 2021, September 30, 2020 and September 30, 2019, respectively. Design Segment The Company applies the “cost to cost” and “right to invoice” methods of revenue recognition to the contracts with customers in the design segment. The design segment typically engages in two types of contracts: (i) time and material and (ii) fixed price. The Company recognizes revenue over time on its time and material contracts utilizing a “right to invoice” method. Revenues from fixed price contracts that require performance of services that are not related to the production of tangible assets are recognized by using cost inputs to measure progress toward the completion of its performance obligations, or the “cost to cost” method. Revenues from fixed price contracts that contain specific deliverables are recognized when the performance obligation has been satisfied or the transfer of goods to the customer has been completed and accepted. 7 FORWARD INDUSTRIES, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Recognized revenues that will not be billed until a later date, or contract assets, are recorded as an asset and classified as a component of accounts receivable in the accompanying condensed consolidated balance sheets. The design segment had contract assets of $ 939,000 , $ 649,000 and $ 611,000 at June 30, 2021, September 30, 2020 and September 30, 2019, respectively. Contracts where collections to date have exceeded recognized revenues, or contract liabilities, are recorded as a liability and classified as a component of deferred income in the accompanying condensed consolidated balance sheets. The design segment had contract liabilities of $ 305,000 , $ 410,000 and $ 220,000 at June 30, 2021, September 30, 2020 and September 30, 2019, respectively. Accounts Receivable Accounts receivable consist of unsecured trade accounts with customers. The Company maintains an allowance for doubtful accounts, which is recorded as a reduction to accounts receivable on the condensed consolidated financial statements. Collectability of accounts receivable is estimated by evaluating the number of days accounts are outstanding, customer payment history, recent payment trends and perceived creditworthiness, adjusted as necessary based on specific customer situations. At June 30, 2021, September 30, 2020 and September 30, 2019, the Company had allowances for doubtful accounts of $ 249,000 , $ 249,000 and $ 159,000 , respectively, for the distribution segment and $ 861,000 , $ 347,000 and $ 2,033,000 , respectively, for the design segment. At June 30, 2021, September 30, 2020 and September 30, 2019, the Company had net accounts receivable of $ 5,282,000 , $ 4,243,000 and $ 4,618,000 , respectively, for the distribution segment and $ 2,402,000 , $ 3,359,000 , and $ 2,077,000 , respectively, for the design segment. Goodwill Goodwill represents the future economic benefits of assets acquired in a business combination that are not individually identified or separately recognized. The Company’s goodwill resulted from its acquisitions of IPS in January 2018 and Kablooe in August 2020. The Company reviews goodwill for impairment at least annually, or more often if triggering events occur. The Company has two reporting units with goodwill (IPS and Kablooe) and we perform our annual goodwill impairment test on September 30, the end of the fiscal year, or upon the occurrence of a triggering event. The Company has the option to perform a qualitative assessment to determine if an impairment is more likely than not to have occurred. If the Company can support the conclusion that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then the Company would not need to perform a quantitative impairment test for the reporting unit. If the Company cannot support such a conclusion or does not elect to perform the qualitative assessment, then the Company will perform the quantitative impairment test by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying value, no impairment charge is recognized. If the fair value of the reporting unit is less than its carrying value, an impairment charge will be recognized for the amount by which the reporting unit’s carrying amount exceeds its fair value. A significant amount of judgment is required in performing goodwill impairment tests including estimating the fair value of a reporting unit. See Note 3. Intangible Assets Intangible assets include trademarks and customer relationships, which resulted from the acquisitions of IPS in January 2018 and Kablooe in August 2020 and are recorded based on their estimated fair value determined in conjunction with the purchase price allocations. These intangible assets are amortized over their estimated useful lives, which are periodically evaluated for reasonableness. Our intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In assessing the recoverability of our intangible assets, we must make estimates and assumptions regarding future cash flows and other factors to determine the fair value of the respective assets. These estimates and assumptions could have a significant impact on whether an impairment charge is recognized and the magnitude of any such charge. Fair value estimates are made at a specific point in time, based on relevant information. These estimates are subjective in nature and involve uncertainties and matters of significant judgments and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates. If these estimates or material related assumptions change in the future, we may be required to record impairment charges related to our intangible assets. Management evaluated and concluded that there were no impairments of intangible assets during the nine months ended June 30, 2021 or 2020. 8 FORWARD INDUSTRIES, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Income Taxes The Company recognizes future tax benefits and liabilities measured at enacted rates attributable to temporary differences between financial statement and income tax bases of assets and liabilities and to net tax operating loss carryforwards to the extent that realization of these benefits is more likely than not. At June 30, 2021, there was no change to our assessment that a full valuation allowance was required against all net deferred tax assets as it is not probable that such deferred tax assets will be realized. Accordingly, any deferred tax provision or benefit was offset by an equal and opposite change to the valuation allowance. No current book income tax provision was recorded against book net income due to the existence of significant net operating loss carryforwards. In December 2020, the Company’s application for forgiveness of its loan received as part of the Payroll Protection Program (“PPP loan”) pursuant to the U.S. Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was approved. The aggregate loan principal amount forgiven was $1,357,000. The total amount forgiven will not be recognized as taxable income pursuant to the CARES Act. Pursuant to the Consolidated Appropriations Act, 2021, which was enacted by Congress and signed into law by the President on December 27, 2020, all expenses utilizing funds from PPP loans will be deductible against taxable income. Fair Value Measurements We perform fair value measurements in accordance with the guidance provided by Accounting Standards Codification (“ASC”) 820, “Fair Value Measurement.” ASC 820 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at their fair values, we consider the principal or most advantageous market in which we would transact and consider assumptions that market participants would use when pricing the assets or liabilities, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset's or liability's categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 establishes three levels of inputs that may be used to measure fair value: · Level 1: quoted prices in active markets for identical assets or liabilities; · Level 2: inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or · Level 3: unobservable inputs that are supported by little or no market activity and that are significant to the fair values of the assets or liabilities. Leases L ease assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term, using the Company’s incremental borrowing rate commensurate with the lease term, since the Company’s lessors do not provide an implicit rate, nor is one readily available. The Company has certain leases that may include an option to renew and when it is reasonably probable to exercise such option, the Company will include the renewal option terms in determining the lease asset and lease liability. Lease assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Operating lease assets are shown as right of use assets and finance lease assets are a component of property and equipment on the condensed consolidated balance sheets. The current and long-term portions of operating and finance lease liabilities are shown separately as such on the condensed consolidated balance sheets. 9 FORWARD INDUSTRIES, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Business Combinations The Company allocates the fair value of purchase consideration to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values. The excess of the purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, the Company makes significant estimates and assumptions, especially with respect to intangible assets. Critical estimates in valuing certain intangible assets include, but are not limited to, future expected cash flows from customer relationships and developed technology, discount rates and terminal values. Our estimates of fair value are based upon assumptions believed to be reasonable, but actual results may differ from estimates. Other estimates associated with the accounting for acquisitions may change as additional information becomes available regarding the assets acquired and liabilities assumed. Recent Accounting Pronouncements In August 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2018-13, “Fair Value Measurement - Disclosure Framework (Topic 820)” to improve the disclosure requirements on fair value measurements. The updated guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted for any removed or modified disclosures. The Company adopted this guidance in the first quarter of Fiscal 2021 with no material impact to its condensed consolidated financial statements. In November 2019, the FASB issued ASU 2019-08, “Compensation – Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606)” to provide guidance for share-based payment awards granted to a customer in conjunction with selling goods or services accounted for under Topic 606. The pronouncement is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. The Company adopted this guidance in the first quarter of Fiscal 2021 with no material impact to its condensed consolidated financial statements. In November 2019, the FASB issued ASU 2019-11, “Codification Improvements to Topic 326, Financial Instruments – Credit Losses.” ASU 2019-11 is an accounting pronouncement that provides clarity to and amends earlier guidance on this topic and would be effective concurrently with the adoption of such earlier guidance. This pronouncement is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. The Company is currently evaluating the effects of this pronouncement on its condensed consolidated financial statements. In August 2018, the FASB issued ASU 2018-15 “ Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)” addressing customers’ accounting for implementation costs incurred in a cloud computing arrangement that is a service contract, which requires customers to apply internal-use software guidance to determine the implementation costs that are able to be capitalized. Capitalized implementation costs are required to be amortized over the term of the arrangement, beginning when the cloud computing arrangement is ready for its intended use. The effective date of the new guidance for public companies is for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted. The Company adopted this guidance in the first quarter of Fiscal 2021 with no material impact to its condensed consolidated financial statements. In December 2019, the FASB issued ASU 2019-12 “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This guidance removes certain exceptions to the general principles in Topic 740 and provides consistent application of U.S. GAAP by clarifying and amending existing guidance. The effective date of the new guidance for public companies is for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the effects of the pronouncement on its condensed consolidated financial statements. 10 FORWARD INDUSTRIES, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS NOTE 3 INTANGIBLE ASSETS AND GOODWILL The Company’s intangible assets are all held under the design segment of our business. Amortization expense related to intangible assets was $ 53,000 and $ 41,000 for the three months ended June 30, 2021 and 2020, respectively, and $ 160,000 and $ 122,000 for the nine months ended June 30, 2021 and 2020, respectively, which is included in general and administrative expenses on the condensed consolidated statements of operations. The Company’s intangible assets consist of the following: Intangible Assets June 30, 2021 September 30, 2020 Trademarks Customer Relationships Total Intangible Assets Trademarks Customer Relationships Total Intangible Assets Gross carrying amount $ 585,000 $ 1,390,000 $ 1,975,000 $ 585,000 $ 1,390,000 $ 1,975,000 Less accumulated amortization ( 115,000 ) ( 488,000 ) ( 603,000 ) ( 86,000 ) ( 358,000 ) ( 444,000 ) Net carrying amount $ 470,000 $ 902,000 $ 1,372,000 $ 499,000 $ 1,032,000 $ 1,531,000 At June 30, 2021, estimated amortization expense for the Company’s intangible assets for each of the next five years and thereafter is as follows: Estimated amortization expense Remainder of Fiscal 2021 $ 53,000 Fiscal 2022 213,000 Fiscal 2023 213,000 Fiscal 2024 213,000 Fiscal 2025 213,000 Thereafter 467,000 Total $ 1,372,000 In March 2020, the Company experienced triggering events that prompted the testing of its goodwill for impairment. Those triggering events included the reduction in fair value of the IPS contingent earnout consideration discussed in Note 4 and revised revenue and operational projections for IPS for the remainder of the 2020 fiscal year and future periods. Based on these factors, the Company concluded that it was more likely than not that the fair value of the IPS reporting unit had declined below its carrying amount. The Company then calculated the fair value of this reporting unit using Level 3 inputs, which is a combination of asset-based, income and market approaches. The estimates and assumptions utilized in the estimated fair value calculation included discount rate, terminal growth rate, selection of peer group companies and control premium applied as well as forecasts of revenue growth rates, gross margins, operating margins and working capital requirements. Any changes in the judgments, estimates or assumptions used could produce significantly different results. The Company concluded the IPS reporting unit’s fair value was below its carrying value by $ 1,015,000 and an impairment charge was recognized for this amount in March 2020. Based on management’s evaluation, there were no further impairments to goodwill at September 30, 2020 and there were no triggering events leading to an interim impairment analysis at June 30, 2021. 11 FORWARD INDUSTRIES, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS NOTE 4 FAIR VALUE MEASUREMENTS The earnout consideration of $ 70,000 and $ 90,000 at June 30, 2021 and September 30, 2020, respectively, represents the fair value of the contingent earnout consideration related to the acquisition of Kablooe. The current and non-current portions of this liability are shown in the corresponding categories on the condensed consolidated balance sheets in each period presented. In December 2020, the Company reduced this liability from $90,000 to $60,000 based on the low likelihood of Kablooe reaching the first year’s earnings target and in June 2021, it increased this liability from $60,000 to $70,000 based on the estimated increase in fair value of earnout payments in future periods. In connection with the acquisition of IPS in January 2018, the Company agreed to pay deferred cash consideration and contingent earnout consideration to the selling shareholders of IPS and these liabilities were measured at fair value each reporting period. In March 2020, the fair value of the earnout consideration was reduced from $350,000 to $0 due to the low likelihood of IPS reaching the underlying earnings target. At September 30, 2020, the Company had no remaining obligation for consideration payments related to the acquisition of IPS. The following table presents the placement in the fair value hierarchy and summarizes the changes in fair value of the earnout liability for the three and nine months ended June 30, 2021: Table of fair value liability measured on recurring basis Fair value measurement at reporting date using Quoted prices in active markets for identical assets Significant other observable inputs Significant unobservable inputs Balance (Level 1) (Level 2) (Level 3) Earnout consideration at September 30, 2020 $ 90,000 $ – $ – $ 90,000 Decrease in fair value of Kablooe earnout consideration ( 30,000 ) – – ( 30,000 ) Earnout consideration at December 31, 2020 60,000 – – 60,000 Change in fair value of Kablooe earnout consideration – – – – Earnout consideration at March 31, 2021 60,000 – – 60,000 Increase in fair value of Kablooe earnout consideration 10,000 – – 10,000 Earnout consideration at June 30, 2021 $ 70,000 $ – $ – $ 70,000 During Fiscal 2019, the Company received common stock from a customer as compensation for services provided, which was recorded as a cost-method investment with an estimated fair value of $327,000. This initial fair value was based on a private placement round of common stock issued to third-party private investors of the customer at a time close to the valuation date. Management determined that the inputs used to value the investment were observable, either directly or indirectly, and therefore classified as a level 2 valuation measurement. In March 2020, due to the performance of the business in which the Company was invested, it concluded the investment was impaired and recorded an impairment charge of $ 327,000 , which was recorded as a component of general and administrative expenses on the condensed consolidated statement of operations. 12 FORWARD INDUSTRIES, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS NOTE 5 SEGMENT INFORMATION The Company has two reportable segments: distribution and design. The distribution segment sources and distributes carrying cases and other accessories for medical monitoring and diagnostic kits and a variety of other portable electronic and non-electronic devices. It also distributes a variety of other products, including smart-enabled furniture, through its retail distribution network. The design segment provides a full spectrum of hardware and software product design and engineering services. We measure the performance of our operating segments based upon revenue and operating income or loss. Operating income/(loss) and net income/(loss) are shown in the table below: Segment operating income (loss) For the Three Months Ended June 30, For the Nine Months Ended June 30, 2021 2020 2021 2020 Revenues, net Distribution $ 5,720,000 $ 6,389,000 $ 15,808,000 $ 15,709,000 Design 4,245,000 3,160,000 12,269,000 10,164,000 Total revenues, net $ 9,965,000 $ 9,549,000 $ 28,077,000 $ 25,873,000 Cost of sales Distribution $ 4,939,000 $ 5,450,000 $ 13,730,000 $ 13,606,000 Design 2,842,000 2,324,000 8,158,000 7,319,000 Total cost of sales $ 7,781,000 $ 7,774,000 $ 21,888,000 $ 20,925,000 Income/(loss) from operations Distribution $ ( 125,000 ) $ ( 211,000 ) $ ( 996,000 ) $ ( 1,032,000 ) Design 393,000 36,000 281,000 ( 839,000 ) Total income/(loss) from operations $ 268,000 $ ( 175,000 ) $ ( 715,000 ) $ ( 1,871,000 ) Other expense/(income), net Distribution $ 56,000 $ 35,000 $ 100,000 $ ( 239,000 ) Design ( 32,000 ) 5,000 ( 1,423,000 ) 36,000 Total other expense/(income), net $ 24,000 $ 40,000 $ ( 1,323,000 ) $ ( 203,000 ) Net income/(loss) Distribution $ ( 181,000 ) $ ( 246,000 ) $ ( 1,096,000 ) $ ( 793,000 ) Design 425,000 31,000 1,704,000 ( 875,000 ) Total net income/(loss) $ 244,000 $ ( 215,000 ) $ 608,000 $ ( 1,668,000 ) The following table presents total assets by operating segment: Schedule of Operating Assets and Liabilities June 30, 2021 September 30, 2020 Distribution $ 8,631,000 $ 8,289,000 Design 10,300,000 11,067,000 Total $ 18,931,000 $ 19,356,000 13 FORWARD INDUSTRIES, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS NOTE 6 SHARE-BASED COMPENSATION 2021 Equity Incentive Plan In February 2021, shareholders of the Company approved the 2021 Equity Incentive Plan (the “2021 Plan”), which is administered by the Compensation Committee of the Board of Directors and authorizes 1,291,000 shares of common stock for grants of various types of equity awards to officers, directors, employees and consultants. Upon approval of the 2021 Plan, no additional awards were granted under the 2011 Long Term Incentive Plan (the “2011 Plan”), which expired according to its terms in March 2021. Shares authorized under the 2021 Plan include 1,000,000 new shares and 291,000 shares that remained available under the 2011 Plan. Awards which are forfeited or expire are eligible for regrant under the 2021 Plan. The exercise prices of stock options granted may not be less than the fair market value of the common stock as quoted on the Nasdaq stock market on the grant date and the expiration date of option awards may not exceed 10 years. Stock Options No options were granted during the three or nine months ended June 30, 2021. In February 2020, the Company granted options to non-employee directors to purchase an aggregate of 248,000 shares of its common stock at an exercise price of $ 1.13 per shares. The options vested one year from the date of grant, expire five years from the date of grant and had an aggregate grant date fair value of $ 145,000 , which was recognized ratably over the vesting period. These options, which were the only options granted during the nine months ended June 30, 2020, had a grant-date fair value of $ 0.58 per share. During the nine months ended June 30, 2021 and 2020, the Company issued 147,000 and 50,000 shares, respectively, of its common stock pursuant to the exercise of stock options for aggregate cash proceeds of $ 234,000 and $ 32,000 , respectively, which had an aggregate intrinsic value of $ 265,000 and $ 33,000 , respectively. The Company recognized compensation expense for stock option awards of $ 4,000 and $ 38,000 during the three months ended June 30, 2021 and 2020, respectively, and $ 66,000 and $ 107,000 during the nine months ended June 30, 2021 and 2020, respectively, in its condensed consolidated statements of operations. At June 30, 2021, there was $ 7,000 of total unrecognized compensation cost related to nonvested stock option awards that is expected to be recognized over a weighted average period of 0.9 years. 14 FORWARD INDUSTRIES, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS   NOTE 7 EARNINGS/(LOSS) PER SHARE Basic earnings/(loss) per share data for each period presented is computed using the weighted average number of shares of common stock outstanding during each such period. Diluted earnings/(loss) per share data is computed using the weighted average number of common and dilutive common equivalent shares outstanding during each period. Dilutive common equivalent shares consist of shares that would be issued upon the exercise of stock options and warrants, computed using the treasury stock method. A reconciliation of basic and diluted earnings/(loss) per share is as follows: Schedule of Earnings Per Share, Basic and Diluted For the Three Months Ended June 30, For the Nine Months Ended June 30, 2021 2020 2021 2020 Numerator: Net income/(loss) $ 244,000 $ ( 215,000 ) $ 608,000 $ ( 1,668,000 ) Denominator: Weighted average common shares outstanding 9,964,000 9,534,000 9,920,000 9,534,000 Dilutive common share equivalents 549,000 – 503,000 – Weighted average diluted shares outstanding 10,513,000 9,534,000 10,423,000 9,534,000 Earnings/(loss) per share Basic $ 0.02 $ ( 0.02 ) $ 0.06 $ ( 0.18 ) Diluted $ 0.02 $ ( 0.02 ) $ 0.06 $ ( 0.18 ) The following securities were excluded from the calculation of diluted earnings/(loss) per share in each period because their inclusion would have been anti-dilutive: Schedule of antidilutive securities excluded For the Three Months Ended June 30, For the Nine Months Ended June 30, 2021 2020 2021 2020 Options 10,000 954,000 10,000 954,000 Warrants – 151,000 – 151,000 Total potentially dilutive shares 10,000 1,105,000 10,000 1,105,000 15 FORWARD INDUSTRIES, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS   NOTE 8 CONCENTRATIONS Concentration of Revenues and Accounts Receivable For the three and nine months ended June 30, 2021 and 2020, the Company had customers whose individual percentage of their respective segment’s revenues and accounts receivable was 10% or greater. The concentrations of revenues and accounts receivable for each reportable segment are as follows: Distribution Segment Revenues Concentration Schedule of concentration percentages For the Three Months Ended June 30, For the Nine Months Ended June 30, 2021 2020 2021 2020 Customer A 11 % 25 % 22 % 31 % Customer B 17 % 16 % 17 % 16 % Customer C 24 % 22 % 25 % 23 % Customer D 9 % 9 % 9 % 9 % Customer E 15 % – 6 % – Totals 76 % 72 % 79 % 79 % Design Segment Revenues Concentration For the Three Months Ended June 30, For the Nine Months Ended June 30, 2021 2020 2021 2020 Customer 1 3 % 29 % 7 % 20 % Customer 2 11 % 14 % 11 % 13 % Customer 3 16 % 11 % 12 % 16 % Customer 4 10 % – 15 % – Customer 9 14 % – 8 % – Total 54 % 54 % 53 % 49 % Distribution Segment Accounts Receivable Concentration June 30, 2021 September 30, 2020 Customer A 12 % 23 % Customer B 24 % 22 % Customer C 18 % 20 % Customer D 7 % 17 % Customer E 18 % – Totals 79 % 82 % 16 FORWARD INDUSTRIES, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS   Design Segment Accounts Receivable Concentration June 30, 2021 September 30, 2020 Customer 1 12 % 24 % Customer 3 18 % 5 % Customer 5 2 % 10 % Customer 6 – 14 % Customer 7 12 % – Customer 8 10 % 8 % Totals 54 % 61 % NOTE 9 RELATED PARTY TRANSACTIONS Buying Agency and Supply Agreement The Company has a Buying Agency and Supply Agreement (the “Supply Agreement”) with Forward Industries Asia-Pacific Corporation (“Forward China”). The Supply Agreement provides that, upon the terms and subject to the conditions set forth therein, Forward China will act as the Company’s exclusive buying agent and supplier of Products (as defined in the Supply Agreement) in the Asia-Pacific region. The Company purchases products at Forward China’s cost and also pays to Forward China a monthly service fee equal to the sum of: (i) $100,000 and (ii) 4% of “Adjusted Gross Profit”, which is defined as the selling price less the cost from Forward China. The Supply Agreement expires October 22, 2023. Terence Wise, Chief Executive Officer and Chairman of the Company, is the owner of Forward China. In addition, Jenny P. Yu, a Managing Director of Forward China, beneficially owns more than 5% of the Company’s common stock. The Company recorded service fees to Forward China of $ 357,000 and $ 346,000 during the three months ended June 30, 2021 and 2020, respectively, and $ 1,040,000 and $ 1,022,000 during the nine months ended June 30, 2021 and 2020, respectively, which are included as a component of cost of sales upon sales of the related products. The Company has a separate agreement with Forward China to address the potential impact of customers sourcing directly from Forward China. In the event a customer bypasses the services of the Company and does business directly with Forward China, Forward China will pay a commission of 50% of the net revenue, less direct costs, generated from the products or services sold. The Company recognized $ 12,000 of commissions related to this agreement during the nine months ended June 30, 2021. No commissions were recognized during the three months ended June 30, 2021 or the three or nine months ended June 30, 2020. The Company had prepayments to Forward China for inventory purchases of $ 137,000 and $ 107,000 at June 30, 2021 and September 30, 2020, respectively, which are included in prepaid expenses and other current assets on the condensed consolidated balance sheets. Promissory Note On January 18, 2018, the Company issued a $ 1,600,000 promissory note payable to Forward China to fund the acquisition of IPS. The promissory note bears an interest rate of 8 % per annum and had an original maturity date of January 18, 2019 . Monthly interest payments commenced on February 18, 2018. The Company incurred and paid $ 32,000 for the three months ended June 30, 2021 and 2020 and $ 96,000 for the nine months ended June 30, 2021 and 2020 in interest expense associated with this note. The maturity date of this note was extended to December 31, 2022 . 17 FORWARD INDUSTRIES, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS   Related Party Sales A member of the Company’s Audit, Governance and Compensation Committees of its Board of Directors is also a member of the Board of Directors of a company to whom the Company’s distribution division sold products. The Company recognized revenue of $ 63,000 from the sale of such products during the three and nine months ended June 30, 2021. The Company’s design division provided services to a customer whose former Chief Operating and Financial Officer and equity owner is an immediate family member of a director on the Company’s Board of Directors. The director is a member of the Board’s Audit, Governance and Compensation Committees. The Company sold design services to this customer of $ 0 and $ 44,000 for the three and nine months ended June 30, 2020, respectively. There were no sales to this customer for the three or nine months ended June 30, 2021. Related Party Activity In October 2020, the Company began selling smart-enabled furniture, which is sourced by Forward China and sold in the U.S. under the Koble brand name. The Koble brand is owned by The Justwise Group Ltd., a company owned by Terrence Wise, Chief Executive Officer and Chairman of the Company. The Company recognized revenues from the sale of Koble products of $ 413,000 and $ 752,000 during the three and nine months ended June 30, 2021, respectively. NOTE 10 LEGAL PROCEEDINGS On August 21, 2020, IPS was named a third-party defendant in a patent dispute claim currently pending in the U.S. District Court for the Eastern District of New York. The complaint, which contains no specific amount of claimed monetary damages, asserts that certain intellectual property was misappropriated by IPS and one of its former employees. IPS denies the allegations, believes the action is without merit and intends to vigorously defend it. The Company filed a motion to dismiss the complaint on December 14, 2020. The court has not yet ruled on the Company’s motion. From time to time, the Company may become a party to other legal actions or proceedings in the ordinary course of its business. At June 30, 2021, there were no such actions or proceedings, either individually or in the aggregate, that, if decided adversely to the Company’s interests, it believes would be material to its business. NOTE 11 LINE OF CREDIT The Company, specifically IPS, has a $ 1,300,000 revolving line of credit with a bank which was renewed at the discretion of the lender in May 2021. The line of credit has a maturity date of May 31, 2022 , is guaranteed by the Company and is secured by all of IPS’ assets. The interest rate on the line of credit is 0.75% above The Wall Street Journal prime rate . The effective interest rate was 4.0 % at both June 30, 2021 and September 30, 2020. In March 2021, the Company paid down the outstanding balance on the line of credit and $ 1,300,000 was available at June 30, 2021. The Company is subject to certain debt-service ratio requirements which are measured annually. At September 30, 2020, the Company was in violation of the required debt-service ratio covenants but was granted a waiver of the violation from the lender. 18 FORWARD INDUSTRIES, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS   NOTE 12 DEBT On April 18, 2020 , the Company entered into a loan in an aggregate principal amount of $ 1,357,000 under the Paycheck Protection Program of the CARES Act. The loan was unsecured, bore interest at a rate of 1 % per annum, and was scheduled to mature on April 18, 2022 . In October 2020, the Company filed for forgiveness of this loan and in December 2020, the Small Business Administration (“SBA”) approved our forgiveness request for this loan. The forgiveness has been accounted for as an extinguishment of debt and the resulting gain has been recorded as forgiveness of note payable on the condensed consolidated statement of operations for the nine months ended June 30, 2021. There is a six-year period during which the SBA can review the Company’s forgiveness. In connection with the acquisition of Kablooe, the Company assumed a loan payable with a principal amount of $ 170,000 . The loan matures in August 2021, bears interest at a rate of 6.0 % per annum and is secured by all of Kablooe’s assets. Interest and principal payments of $ 15,000 are payable monthly until maturity. The outstanding balance at June 30, 2021 and September 30, 2020 was $ 29,000 and $ 156,000 , respectively. NOTE 13 MOONI AGREEMENT On January 29, 2019, the Company entered into a three-year Distribution Agreement (the “Agreement”) with Mooni International AB (“Mooni”) and its owner. In accordance with the Agreement, the Company (i) was appointed as the exclusive distributor of Mooni's current and future products (including future products developed or offered by Mooni and/or the owner) in North America, (ii) subject to certain repayment requirements, paid $400,000 to Mooni, and (iii) was granted an option to purchase a controlling interest of Mooni at a valuation not to exceed $5 million which, if exercised, would have been effective on the 12-month anniversary of the effective date of the Agreement. This option was not exercised and therefore expired. Additionally, Forward China, a company owned by Terence Wise, the Company's Chairman and Chief Executive Officer, was named the designated supplier under the Agreement. The Company generated revenues from this agreement of $ 459,000 since it began selling Mooni products in Fiscal 2020. The current and long-term portions of the unamortized fee of $ 78,000 and $ 0 , respectively, at June 30, 2021 and $ 133,000 and $ 45,000 , respectively, at September 30, 2020, are included in prepaid expenses and other current assets and other assets, respectively, in the accompanying condensed consolidated financial statements. Amortization of the cost for the three and nine months ended June 30, 2021 of $ 33,000 and $ 100,000 , respectively, and for the three and nine months ended June 30, 2020 of $ 33,000 and $ 100,000 , respectively, is included in sales and marketing expenses in the accompanying condensed consolidated statements of operations. NOTE 14 LEASES The Company’s operating leases are primarily for corporate, sales and administrative office space. Total operating lease expense was $ 150,000 and $ 455,000 for the three and nine months ended June 30, 2021, respectively, and $ 127,000 and $ 382,000 for the three and nine months ended June 30, 2020, respectively, and is recorded in sales and marketing and general and administrative expenses on the condensed consolidated statements of operations. The Company leases certain computer equipment through various finance lease agreements expiring through July 2022. The net book value of assets under finance leases was $ 16,000 and $ 23,000 at June 30, 2021 and September 30, 2020, respectively. In March 2021, the Company signed a renewal to extend the term of its lease in Minnesota for an additional 60 months. Payments under this operating lease commence July 1, 2021 and escalate 2.75% per year. The monthly rent payment is $10,000 per month, which includes taxes and operating expenses as defined in the agreement. 19 FORWARD INDUSTRIES, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Additional information related to operating and finance leases at June 30, 2021 and September 30, 2020 is as follows: Additional information related to operating and finance leases June 30, September 30, 2021 2020 Weighted Average Remaining Lease Term (Yrs): Operating leases 9.5 10.9 Finance leases 0.8 0.9 Weighted Average Discount Rate: Operating leases 5.7 % 5.7 % Finance leases 5.8 % 5.8 % At June 30, 2021, future minimum payments under non-cancellable operating and finance leases were as follows: Schedule of future minimum payments under operating & financial leases Operating Leases Finance Leases Remainder of Fiscal 2021 $ 148,000 $ 2,000 Fiscal 2022 554,000 4,000 Fiscal 2023 554,000 – Fiscal 2024 565,000 – Fiscal 2025 531,000 – Thereafter 2,908,000 – Total future minimum lease payments 5,260,000 6,000 Less imputed interest ( 1,266,000 ) ( 2,000 ) Present value of lease liabilities $ 3,994,000 $ 4,000 20 ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion and analysis should be read in conjunction with our unaudited condensed consolidated financial statements, and the notes thereto, and other financial information appearing elsewhere in this Quarterly Report on Form 10-Q and the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2020. The following discussion and analysis compares our consolidated results of operations for the three and nine months ended June 30, 2021 (the “2021 Quarter” and the “2021 Period”, respectively) with those for the three and nine months ended June 30, 2020 (the “2020 Quarter” and the “2020 Period”, respectively). All dollar amounts and percentages presented herein have been rounded to approximate values. Cautionary Note Regarding Forward-Looking Statements This report contains “forward-looking statements”, as such term is used within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, among other things, statements regarding: · our liquidity, · expectations regarding the impact of the pandemic on our business, · expectations regarding the length of the pandemic’s business disruption, · expectations regarding revenues, · plans regarding the repayment of debt, and · beliefs regarding our capital resources as well as other statements regarding our future operations, financial condition and prospects and business strategies. Forward-looking statements can be identified by words such as “anticipates,” “intends,” “plans,” “seeks,” “believes,” “estimates,” “expects,” “predicts,” “projects,” “will be” and “will continue” and similar expressions. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you therefore against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements include the failure to receive material orders, our ability to successfully market and sell products that we develop, the effects of the COVID-19 outbreak, including levels of consumer, business and economic confidence generally, the duration of the COVID-19 outbreak and severity of such outbreak, the pace of recovery following the COVID-19 outbreak, the effect on our supply chain, our ability to implement cost containment; and the adverse effects of the COVID-19 outbreak on our business or the market price of our common stock, failure to diversify the industries in which we sell our products, potential imposed tariffs or other restrictions placed on imports by the U.S. government, and continued pricing pressure on our products. Further information on our risk factors is contained in our filings with the SEC, including our Form 10-K for the year ended September 30, 2020. Any forward-looking statement made by us speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. 21 Business Overview Forward Industries, Inc. is a fully integrated design, development and manufacturing solution provider for top tier medical and technology customers worldwide. As a result of the continued expansion of our design and development capabilities through our wholly-owned subsidiaries, IPS and Kablooe, we are now able to introduce proprietary products to the market from concepts brought to us from a number of different sources, both inside and outside the Company. The acquisition of Kablooe took place in August 2020 and its results of operations have been included in our condensed consolidated financial statements since the acquisition date. Accordingly, our results of operations for the 2021 Quarter and the 2021 Period include Kablooe’s results of operations, while our results of operations for the 2020 Quarter and the 2020 Period do not. Key terms of the acquisition are contained in our Form 10-K filed with the Securities and Exchange Commission on December 17, 2020. The future impacts of the COVID-19 pandemic and any resulting economic impact are largely unknown and could be significant. It is possible that the COVID-19 pandemic, the measures taken by the governments of countries affected and the resulting economic impact may continue to negatively impact our results of operations, cash flows and financial position in future periods as well as that of our customers, including their ability to pay for our services and choosing to allocate their budgets to new or existing projects which may or may not require our services. The long-term financial impact on our business cannot be reasonably estimated at this time. As a result, the effects of COVID-19 may not be fully reflected in our financial results until future periods. Until the pandemic is fully controlled, we expect business conditions to remain challenging. In response to these challenges, we will continue to focus on those factors that we can control: closely managing and controlling our expenses; aligning our design and development schedules with demand in a proactive manner as there are changes in market conditions to minimize our cash operating costs; pursuing further improvements in the productivity and effectiveness of our development, selling and administrative activities and, where appropriate, taking advantage of opportunities to enhance our business growth and strategy. To help mitigate the impact of these challenging business conditions, we implemented cost-cutting initiatives and reduced executive pay and Board of Directors compensation for the three months ended June 30, 2021. See “Liquidity and Capital Resources” section for further description of these cost-cutting measures. Refer to “Part II, Item 1A — Risk Factors” for a description of the material risks that the Company currently faces in connection with COVID-19. Variability of Revenues and Results of Operations A significant portion of our revenue is concentrated with several large customers, some of which are the same and some of which change over time. Orders from some of these customers can be highly variable, with short lead times, which can cause our quarterly revenues, and consequently our results of operations, to vary over a relatively short period of time. Critical Accounting Policies and Estimates We discuss the material accounting policies that are critical in making the estimates and judgments in our Annual Report on Form 10-K for the fiscal year ended September 30, 2020, under the caption “Management’s Discussion and Analysis—Critical Accounting Policies and Estimates”. There has been no material change in critical accounting policies or estimates during the period covered by this report. Recent Accounting Pronouncements For information on recent accounting pronouncements and impacts, see Note 2 to the unaudited condensed consolidated financial statements. 22 RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2021 COMPARED TO THE THREE MONTHS ENDED JUNE 30, 2020 Net Income/(Loss) Distribution Segment Distribution segment net loss was $181,000 in the 2021 Quarter compared to 246,000 in the 2020 Quarter. The decrease to the net loss was due to various factors, including a reduction in general and administrative expenses, partially offset by lower revenue and gross profit, as reflected in the table below. Design Segment Design segment net income was $425,000 in the 2021 Quarter compared to $31,000 in the 2020 Quarter. The increase in net income was primarily due to higher revenue and gross profit, partially offset by higher general and administrative expenses, as reflected in the table below: Main Components of Net Income/(Loss) (amounts in thousands) 2021 Quarter 2020 Quarter Increase (Decrease) Consolidated Distribution Design Consolidated Distribution Design Consolidated Net revenues $ 9,965 $ 5,720 $ 4,245 $ 9,549 $ 6,389 $ 3,160 $ 416 Gross profit $ 2,183 $ 781 $ 1,402 $ 1,775 $ 939 $ 836 $ 408 Sales and marketing expenses 621 521 100 464 364 100 157 General and administrative expenses 1,294 385 909 1,486 786 700 (192 ) Operating income/(loss) 268 (125 ) 393 (175 ) (211 ) 36 443 Other expense/(income), net 24 56 (32 ) 40 35 5 (16 ) Net income/(loss) $ 244 $ (181 ) $ 425 $ (215 ) $ (246 ) $ 31 $ 459 Basic and diluted earnings/(loss) per share were $0.02 and $(0.02), respectively, for the 2021 Quarter and the 2020 Quarter. Net Revenues Distribution Segment Net revenues in the distribution segment decreased $669,000, or 10.5%, to $5,720,000 in the 2021 Quarter from $6,389,000 in the 2020 Quarter, the result of a decrease in diabetic product line revenue, partially offset by an increase in other product revenue. Revenues from diabetic products decreased $1,374,000 and revenue from other products increased $705,000. In future periods, as we continue to focus on expanding and diversifying our other product offerings, we believe other product sales will represent a larger portion of our total distribution revenue. As consumer demand increases for diabetic testing products which require no carrying case, we expect diabetic product sales to represent a smaller portion of our distribution revenue. 23 The following tables set forth revenues by channel, product line and geographic location of our distribution segment customers for the periods indicated: Net Revenues for the 2021 Quarter (amounts in thousands) Americas APAC EMEA Total Diabetic products $ 457 $ 1,502 $ 1,561 $ 3,520 Other products 1,673 413 114 2,200 Total net revenues $ 2,130 $ 1,915 $ 1,675 $ 5,720 Net Revenues for the 2020 Quarter (amounts in thousands) Americas APAC EMEA Total Diabetic products $ 1,317 $ 1,498 $ 2,079 $ 4,894 Other products 1,191 259 45 1,495 Total net revenues $ 2,508 $ 1,757 $ 2,124 $ 6,389 Diabetic Product Revenues Our distribution segment manufactures to the order of, and sells carrying cases for, blood glucose diagnostic kits directly to original equipment manufacturers (“OEM”s) or their contract manufacturers. The OEM customer or its contract manufacturer packages our carrying cases “in box” as a custom accessory for the OEM’s blood glucose testing and monitoring kits, or to a lesser extent, sells them through their retail distribution channels. Revenues from diabetic products decreased $1,374,000, or 28.1%, to $3,520,000 in the 2021 Quarter from $4,894,000 in the 2020 Quarter. This decrease was primarily due to lower revenues from one major diabetic products customer (Diabetic Products Customer A), coupled with smaller decreases from all other diabetic products customers. As mentioned above, management believes that revenues from diabetic products customers will continue to decline in future periods. The following table sets forth our distribution segment net revenues by diabetic products customer for the periods indicated: Diabetic Revenues (amounts in thousands) 2021 Quarter 2020 Quarter Increase (Decrease) Diabetic Products Customer A $ 641 $ 1,591 $ (950 ) Diabetic Products Customer B 991 1,010 (19 ) Diabetic Products Customer C 1,369 1,396 (27 ) Diabetic Products Customer D 499 576 (77 ) All other Diabetic Products Customers 20 321 (301 ) Total Diabetic Revenue $ 3,520 $ 4,894 $ (1,374 ) Revenues from diabetic products represented 62% of our distribution segment’s net revenues in the 2021 Quarter compared to 77% in the 2020 Quarter. 24 Other Product Revenues Other product revenues include cases and protective solutions sourced and sold to OEMs for a diverse array of portable electronic and non-electronic products (such as sporting and recreational products, bar code scanners, GPS location devices, tablets and firearms) on a made-to-order basis that are customized to fit the products sold by our OEM customers. Other product revenues also include sales of a variety of other products, such as smart-enabled furniture, sold through our retail distribution network. Revenues from other products increased $705,000, or 47.2%, to $2,200,000 in the 2021 Quarter from $1,495,000 in the 2020 Quarter. The increase was driven by sales to one new customer, which comprised $868,000 of our total distribution revenue for the 2021 Quarter. Other factors contributing to the variance include an increase in sales of non-medical cases, partially offset by a decrease in sales of other products. We will continue to focus on our sales and sales support teams in our continued efforts to expand and diversify our other products customer base as well as take advantage of opportunities to source other products. Revenues from other products represented 38% of our distribution segment’s net revenues in the 2021 Quarter compared to 23% in the 2020 Quarter. Design Segment Net revenues in the design segment increased $1,084,000, or 34.3%, to $4,244,000 in the 2021 Quarter from $3,160,000 in the 2020 Quarter, primarily driven by revenues generated by Kablooe, which was acquired in August 2020. The remaining increase was driven by revenue from new customers, an increase in revenue from existing customers, partially offset by a decline in revenue from certain other customers as projects were either completed or spending was reduced in response to COVID-19. The following table sets forth our design segment net revenues by major customers for the periods indicated: Design Revenues (amounts in thousands) 2021 Quarter 2020 Quarter Increase (Decrease) Design Segment Customer 1 $ 136 $ 922 $ (786 ) Design Segment Customer 2 462 454 8 Design Segment Customer 3 675 352 323 Design Segment Customer 4 427 – 427 Design Segment Customer 9 606 – 606 All other Design Segment Customers 1,938 1,432 506 Total design segment revenues $ 4,244 $ 3,160 $ 1,084 Gross Profit Distribution Segment Gross profit for the distribution segment decreased $158,000, or 16.8%, to $781,000 in the 2021 Quarter as compared to $939,000 in the 2020 Quarter, and gross margin declined from 14.7% to 13.7% in the same period. The decrease in both gross profit and margin are driven by higher freight costs due to the global shipping container shortage caused in part by the pandemic. This decrease in profit margin was also impacted by the continued decline in gross margin on diabetic products due to a shift to lower margin cases and pricing pressures on diabetic products from customers. We continue to work on expanding our product offering to include higher margin products and enhancing our sales efforts to grow revenue and increase gross profit. 25 Design Segment Gross profit for the design segment increased $566,000, or 67.7%, to $1,402,000 in the 2021 Quarter from $836,000 in the 2020 Quarter. Gross margin improved from 26.5% to 33.0% in the same period. The acquisition of Kablooe in August 2020 represented almost half of the improvement in both gross profit and margin in the 2021 Quarter, with the remaining increase driven by an increase in revenue and better utilization rates in the IPS business. Depreciation expense, which is allocated to cost of sales for the design segment, was $22,000 and $21,000 for the 2021 Quarter and 2020 Quarter, respectively. Sales and Marketing Expenses Distribution Segment Sales and marketing expenses for the distribution segment increased $157,000, or 43.1%, to $521,000 in the 2021 Quarter from $364,000 in the 2020 Quarter. The increase was primarily due to an increase in advertising expenses and sales commissions as we continue our efforts to expand and diversify our product offerings. Sales and marketing expenses for the distribution segment increased to 9.1% of revenues in the 2021 Quarter as compared to 5.7% of revenues in the 2020 Quarter. Design Segment Sales and marketing expenses for the design segment remained flat at $100,000 in the 2021 Quarter and the 2020 Quarter. The $12,000 of sales and marketing expenses generated by Kablooe, which was acquired in August 2020, were offset by lower payroll costs. Sales and marketing expenses for the design segment decreased to 2.4% of revenues in the 2021 Quarter from 3.2% of revenues in the 2020 Quarter. General and Administrative Expenses Distribution Segment General and administrative expenses in the distribution segment decreased $401,000, or 51.0%, to $385,000 in the 2021 Quarter from $786,000 in the 2020 Quarter. The decrease primarily resulted from the salary reductions taken as part of our cost-cutting measures enacted in April 2021, the reduction in severance costs and a decrease in professional fees. General and administrative expenses for the distribution segment decreased to 6.7% of revenues in the 2021 Quarter as compared to 12.3% of revenues in the 2020 Quarter. Design Segment General and administrative expenses for the design segment increased $209,000, or 29.9%, to $909,000 in the 2021 Quarter from $700,000 in the 2020 Quarter. The increase is primarily driven by general and administrative costs of $255,000 generated by Kablooe, which was acquired in August 2020, partially offset by lower professional fees. General and administrative expenses for the design segment decreased to 21.4% of revenues in the 2021 Quarter as compared to 22.2% of revenues in the 2020 Quarter. Other Income / (Expense) Distribution Segment The distribution segment reported other expense of $56,000 in the 2021 Quarter as compared to $35,000 in the 2020 Quarter. The increase in other expense relates to the increase in the fair value of the contingent earnout liability coupled with higher interest expense. 26 Design Segment The design segment reported other income of $32,000 in the 2021 Quarter as compared to other expense of $5,000 in the 2020 Quarter, primarily related to interest income on the note receivable from a customer which was fully reserved in Fiscal 2019 and lower interest expense resulting from the paydown of the line of credit in March 2021. Income Taxes For the 2021 Quarter, the Company generated net income of $244,000. The Company maintains significant net operating loss carryforwards and does not recognize income tax expense / (benefit) as its deferred tax provision is typically offset by a full valuation allowance on its net deferred tax asset. RESULTS OF OPERATIONS FOR THE NINE MONTHS ENDED JUNE 30, 2021 COMPARED TO THE NINE MONTHS ENDED JUNE 30, 2020 Net Income/(Loss) Distribution Segment Distribution segment net loss was $1,096,000 in the 2021 Period compared to $793,000 in the 2020 Period. The increase to the net loss was primarily due to an increase in sales and marketing expenses, the reduction in other income resulting from non-cash fair value adjustments to acquisition related earnout liabilities (see Note 4 of the condensed consolidated financial statements), partially offset by lower general and administrative expenses, as reflected in the table below. Design Segment Design segment net income was $1,704,000 in the 2021 Period compared to a net loss of $875,000 in the 2020 Period. The net income generated in the 2021 Period primarily resulted from the $1,357,000 forgiveness of note payable associated with the PPP loan. A reduction in impairment charges (see Notes 3 and 4 of the condensed consolidated financial statements) and higher gross profit were partially offset by higher general and administrative expenses, as reflected in the table below: Main Components of Net Income/(Loss) (amounts in thousands) 2021 Period 2020 Period Increase (Decrease) Consolidated Distribution Design Consolidated Distribution Design Consolidated Net revenues $ 28,077 $ 15,808 $ 12,269 $ 25,873 $ 15,709 $ 10,164 $ 2,204 Gross profit $ 6,189 $ 2,078 $ 4,111 $ 4,948 $ 2,103 $ 2,845 $ 1,241 Sales and marketing expenses 1,802 1,488 314 1,479 1,106 373 323 General and administrative expenses 5,102 1,586 3,516 4,325 2,029 2,296 777 Goodwill impairment – – – 1,015 – 1,015 (1,015 ) Operating (loss)/income (715 ) (996 ) 281 (1,871 ) (1,032 ) (839 ) 1,156 Other (income)/expense, net (1,323 ) 100 (1,423 ) (203 ) (239 ) 36 (1,120 ) Net income/(loss) $ 608 $ (1,096 ) $ 1,704 $ (1,668 ) $ (793 ) $ (875 ) $ 2,276 Basic and diluted earnings/(loss) per share were $0.06 and $(0.18), respectively, for the 2021 Period and the 2020 Period. 27 Net Revenues Distribution Segment Net revenues in the distribution segment increased $99,000, or 0.6%, to $15,808,000 in the 2021 Period from $15,709,000 in the 2020 Period, primarily due to an increase in other product revenue. Revenues from other products increased $1,436,000, which was partially offset by a decline in revenue from diabetic products of $1,337,000. In future periods, we believe other product sales will continue to increase while diabetic product sales will continue to decline. The following tables set forth revenues by channel, product line and geographic location of our distribution segment customers for the periods indicated: Net Revenues for the 2021 Period (amounts in thousands) Americas APAC EMEA Total Diabetic products $ 3,009 $ 4,316 $ 4,500 $ 11,825 Other products 2,989 834 160 3,983 Total net revenues $ 5,998 $ 5,150 $ 4,660 $ 15,808 Net Revenues for the 2020 Period (amounts in thousands) Americas APAC EMEA Total Diabetic products $ 3,984 $ 3,958 $ 5,220 $ 13,162 Other products 1,826 580 141 2,547 Total net revenues $ 5,810 $ 4,538 $ 5,361 $ 15,709 Diabetic Product Revenues Our distribution segment manufactures to the order of, and sells carrying cases for, blood glucose diagnostic kits directly to OEMs (or their contract manufacturers). The OEM customer or its contract manufacturer packages our carrying cases “in box” as a custom accessory for the OEM’s blood glucose testing and monitoring kits, or to a lesser extent, sells them through their retail distribution channels. Revenues from diabetic products decreased $1,337,000, or 10.2%, to $11,825,000 in the 2021 Period from $13,162,000 in the 2020 Period. This decrease was primarily due to lower revenues from one major diabetic products customer (Diabetic Products Customer A), which was partially offset by a net increase in revenue from all other diabetic products customers, of which no changes were individually significant. As mentioned above, management believes that revenues from diabetic products customers will continue to decline in future periods. 28 The following table sets forth our distribution segment net revenues by diabetic products customer for the periods indicated: Diabetic Revenues (amounts in thousands) 2021 Period 2020 Period Increase (Decrease) Diabetic Products Customer A $ 3,490 $ 4,906 $ (1,416 ) Diabetic Products Customer B 2,761 2,586 175 Diabetic Products Customer C 3,892 3,597 295 Diabetic Products Customer D 1,451 1,345 106 All other Diabetic Products Customers 231 728 (497 ) Total Diabetic Revenue $ 11,825 $ 13,162 $ (1,337 ) Revenues from diabetic products represented 75% of our distribution segment’s net revenues in the 2021 Period compared to 84% in the 2020 Period. Other Product Revenues Other product revenues include cases and protective solutions sourced and sold to OEMs for a diverse array of portable electronic and non-electronic products (such as sporting and recreational products, bar code scanners, GPS location devices, tablets and firearms) on a made-to-order basis that are customized to fit the products sold by our OEM customers. Other product revenues also include sales of a variety of other products, such as smart-enabled furniture, sold through our retail distribution network. Revenues from other products increased $1,436,000, or 56.4%, to $3,983,000 in the 2021 Period from $2,547,000 in the 2020 Period. The increase was driven by sales to one new customer, which comprised $947,000 of our total distribution revenue for the 2021 Period. The increase in sales of non-medical cases and protective solutions, both driven by an increase in customers and higher sales volume, comprised the remainder of the increase. We will continue to focus on our sales and sales support teams in our continued efforts to expand and diversify our other products customer base as well as take advantage of opportunities to source other products. Revenues from other products represented 25% of our distribution segment’s net revenues in the 2021 Period compared to 16% in the 2020 Period. Design Segment Net revenues in the design segment increased $2,105,000, or 20.7%, to $12,269,000 in the 2021 Period from $10,164,000 in the 2020 Period, primarily driven by revenues generated by Kablooe, which was acquired in August 2020. The remaining variance was driven by an increase in revenue from new business from both new and existing customers, partially offset by a decline in revenue from certain existing customers as projects were either completed or customer spending was reduced in response to COVID-19. The following table sets forth our design segment net revenues by major customers for the periods indicated: Design Revenues (amounts in thousands) 2021 Period 2020 Period Increase (Decrease) Design Segment Customer 1 $ 825 $ 2,005 $ (1,180 ) Design Segment Customer 2 1,326 1,351 (25 ) Design Segment Customer 3 1,430 1,649 (219 ) Design Segment Customer 4 1,798 – 1,798 All other Design Segment Customers 6,890 5,159 1,731 Total design segment revenues $ 12,269 $ 10,164 $ 2,105 29 Gross Profit Distribution Segment Gross profit for the distribution segment decreased $25,000, or 1.2%, to $2,078,000 in the 2021 Period as compared to $2,103,000 in the 2020 Period, and gross margin declined from 13.4% to 13.1% in the same period. The decrease in both gross profit and margin are driven by higher freight costs due to the global shipping container shortage caused in part by the pandemic and the continued decline in gross margin on diabetic products due to a shift to lower margin cases and pricing pressures on diabetic products from customers. We continue to work on expanding our product offering to include higher margin products and enhancing our sales efforts to grow revenue and increase gross profit. Design Segment Gross profit for the design segment increased $1,266,000, or 44.5%, to $4,111,000 in the 2021 Period from $2,845,000 in the 2020 Period. Gross margin improved from 28.0% to 33.5% in the same period. The acquisition of Kablooe accounted for the majority of the increase in both gross profit and margin in the 2021 Period. Higher revenue and better utilization rates contributed to the remainder of the increase. Depreciation expense, which is allocated to cost of sales for the design segment, was $83,000 and $75,000 for the 2021 Period and 2020 Period, respectively. Sales and Marketing Expenses Distribution Segment Sales and marketing expenses for the distribution segment increased $382,000, or 34.5%, to $1,488 ,000 in the 2021 Period from $1,106,000 in the 2020 Period. The increase was primarily due to an increase in advertising costs and sales commissions as we continue our efforts to expand and diversify our product offerings. Sales and marketing expenses for the distribution segment increased to 9.4% of revenues in the 2021 Period as compared to 7.0% of revenues in the 2020 Period. Design Segment Sales and marketing expenses for the design segment decreased $59,000, or 15.8%, to $314,000 in the 2021 Period from $373,000 in the 2020 Period. The decrease in sales and marketing expenses is primarily due to lower payroll costs and was partially offset by $32,000 of marketing expenses generated by Kablooe, which was acquired in August 2020. Sales and marketing expenses for the design segment decreased to 2.6% of revenues in the 2021 Period from 3.7% of revenues in the 2020 Period. General and Administrative Expenses Distribution Segment General and administrative expenses in the distribution segment decreased $443,000, or 21.8%, to $1,586,000 in the 2021 Period from $2,029,000 in the 2020 Period. The decrease was primarily driven by from the salary reductions taken as part of our cost-cutting measures enacted in April 2021, the reduction in severance costs and a decrease in professional fees. General and administrative expenses for the distribution segment decreased to 10.0% of revenues in the 2021 Period as compared to 12.9% of revenues in the 2020 Period. Design Segment General and administrative expenses for the design segment increased $1,220,000, or 53.1%, to $3,516,000 in the 2021 Period from $2,296,000 in the 2020 Period. The increase is primarily driven by general and administrative costs of $762,000 generated by Kablooe, which was acquired in August 2020, a $623,000 increase in bad debt expense and a $266,000 increase in payroll related costs, partially offset by a decrease in impairment charges (see Note 4 of the condensed consolidated financial statements) and lower professional fees. General and administrative expenses for the design segment increased to 28.7% of revenues in the 2021 Period as compared to 22.6% of revenues in the 2020 Period. 30 Other Income / (Expense) Distribution Segment The distribution segment reported other expense of $100,000 in the 2021 Period as compared to other income of $239,000 in the 2020 Period. The variance is primarily due to the decrease in other income related to fair value adjustments associated with contingent earnout liabilities (see Note 4 of the condensed consolidated financial statements). Design Segment The design segment reported other income of $1,423,000 in the 2021 Period as compared to other expense of $36,000 in the 2020 Period. The primary component of other income in the 2021 Period was the $1,357,000 forgiveness of note payable related to the PPP loan. Other less significant factors contributing to the change were interest income on the note receivable from a customer which was fully reserved for in Fiscal 2019 and lower interest expense due to a reduction in the average amount of debt outstanding. Income Taxes For the 2021 Period, the Company generated net income of $608,000, primarily resulting from the $1,357,000 forgiveness of the PPP loan, which will not be recognized as taxable income per the CARES Act. The Company maintains significant net operating loss carryforwards and does not recognize income tax expense / (benefit) as its deferred tax provision is typically offset by a full valuation allowance on its net deferred tax asset. LIQUIDITY AND CAPITAL RESOURCES Our primary source of liquidity is our operations. The primary demands on our working capital have historically been (i) operating losses, (ii) repayment of debt obligations, and (iii) any increases in accounts receivable and inventories arising in the ordinary course of business. Historically, our sources of liquidity have been adequate to satisfy working capital requirements arising in the ordinary course of business. At June 30, 2021, our working capital was $5,571,000 compared to $3,396,000 at September 30, 2020. The improvement in working capital was primarily due to the extension of the note payable to Forward China. Our largest vendor is Forward China, a related entity, which is able to extend payment terms on outstanding liabilities when necessary (see Note 9 of the condensed consolidated financial statements). We can provide no assurances that any such extension will be given if requested. In an abundance of caution and to proactively conserve the Company’s cash flow, we implemented certain cost-cutting measures which became effective in April 2021. These cost-cutting measures included (i) our executive officers agreeing to a temporary pay cut and our Chief Executive Officer temporarily forgoing his base salary, (ii) a reduction in our head count and amounts paid to outside consultants and (iii) non-employee Board members agreeing to reduce their board fees. These cost-cutting measures ended in June 2021 and compensation was returned to pre-existing amounts in July 2021. The Company estimates that these pay cuts and other reductions resulted in approximately $200,000 of cash savings in the third quarter of Fiscal 2021. The Company will reevaluate any future need for these or similar cost-cutting measures as business conditions warrant. In light of these circumstances, the Compensation Committee of the Board of Directors deferred a recommendation for director equity compensation until such time as the Company’s performance improved. Therefore, in addition to cash savings, the resulting reduction in equity compensation lowered the Company’s non-cash expenses in the third quarter of Fiscal 2021 and will continue to lower the Company’s non-cash expenses in future periods until any new equity grants are awarded. At July 31, 2021, we had approximately $1,015,000 cash on hand and $1,300,000 available under our line of credit which matures May 31, 2022. Additionally, Forward China holds a $1,600,000 promissory note which matures December 31, 2022. Although this note has been extended on multiple occasions to assist us with our liquidity position, we plan on funding the repayment at maturity using existing cash balances and/or obtaining an additional credit facility as deemed necessary. We can provide no assurance that Forward China will extend the note again if we request an extension nor that any such credit facility will be available on terms acceptable to us or at all. 31 We anticipate that our liquidity and financial resources will be adequate to manage our operating and financial requirements until at least September 30, 2022. If we have the opportunity to make a strategic acquisition (as we have in the past with the acquisitions of IPS and Kablooe) or an investment in a product or partnership, we may require additional capital beyond our current cash balance to fund the opportunity. If we seek to raise additional capital, there is no assurance that we will be able to raise funds on terms that are acceptable to us or at all. Although we do not anticipate the need to purchase additional material capital assets in order to carry out our business, it may be necessary for us to purchase equipment and other capital assets in the future, depending on need. Cash Flows During the nine months ended June 30, 2021 and 2020, our sources and uses of cash were as follows: Operating Activities During the 2021 Period, cash used in operating activities of $338,000 primarily resulted from an operating loss of $715,000, an increase in inventories of $631,000, an increase in accounts receivable of $595,000, and the net change in other operating assets and liabilities of $72,000, partially offset by an increase of $855,000 in accounts payable and amounts due to Forward China and non-cash expenses of $820,000 relating to depreciation, amortization, share-based compensation and bad debt expense. During the 2020 Period, cash used in operating activities of $760,000 primarily resulted from an operating loss of $1,871,000, an increase in accounts receivable of $1,448,000, bad debt recoveries of $121,000, a decrease in accounts payable, amounts due to Forward China, accrued expenses and other liabilities of $105,000 and net changes in other operating assets and liabilities of $53,000, partially offset by a decline in inventories of $881,000, an increase in deferred income of $306,000, non-cash impairment charges of $1,342,000 and other non-cash expenses of $309,000 relating to depreciation, amortization, and share-based compensation. Investing Activities Cash used in investing activities in the 2021 Period and the 2020 Period of $61,000 and $56,000, respectively, resulted from purchases of property and equipment. Financing Activities In the 2021 Period, cash used in financing activities of $921,000 consisted of net repayments of the line of credit of $1,000,000 and repayments of notes payable and finance leases of $155,000, partially offset by proceeds from stock options exercised of $234,000. In the 2020 Period, cash provided by financing activities of $808,000 consisted of $1,357,000 proceeds from the PPP loan and $32,000 of proceeds from stock options exercised, partially offset by $300,000 in net repayments on the line of credit, $200,000 paid in deferred cash consideration and $81,000 in repayments of notes payable and finance leases. Related Party Transactions For information on related party transactions and their financial impact, see Note 9 to the unaudited condensed consolidated financial statements contained herein. 32 ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK Not applicable. ITEM 4. CONTROLS AND PROCEDURES Evaluation of Disclosure Controls and Procedures . Our management carried out an evaluation, with the participation of our Principal Executive Officer and Principal Financial Officer, required by Rule 13a-15 and Rule 15d-15 of the Securities Exchange Act of 1934 (the “Exchange Act”) of the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act. Based on its evaluation, our management has concluded that our disclosure controls and procedures are effective as of the end of the period covered by this report to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Changes in Internal Control Over Financial Reporting . There were no changes in our internal control over financial reporting as defined in Rule 13a-15(f) and Rule 15d-15(f) under the Exchange Act that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Limitations of the Effectiveness of Controls and Procedures . A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations of any control system, no evaluation of controls can provide absolute assurance that all control issues, if any, within a company have been detected. 33 PART II. OTHER INFORMATION ITEM 1. LEGAL PROCEEDINGS On August 21, 2020, IPS was named a third-party defendant in a patent dispute claim currently pending in the U.S. District Court for the Eastern District of New York. The complaint, which contains no specific amount of claimed monetary damages, asserts that certain intellectual property was misappropriated by IPS and one of its former employees. IPS denies the allegations, believes the action is without merit and intends to vigorously defend it. The Company filed a motion to dismiss the complaint on December 14, 2020. The court has not yet ruled on the Company’s motion. From time to time, the Company may become a party to other legal actions or proceedings in the ordinary course of its business. At June 30, 2021, there were no such actions or proceedings, either individually or in the aggregate, that, if decided adversely to the Company’s interests, it believes would be material to its business. ITEM 1A. RISK FACTORS The ongoing COVID-19 pandemic and measures intended to prevent its spread have had, and may continue to have, a material and adverse effect on our business and results of operations. Global health concerns relating to the COVID-19 pandemic and related government actions taken to reduce the spread of the virus have been weighing on the macroeconomic environment, and the pandemic has significantly increased economic uncertainty and reduced economic activity. Small businesses, which represent a large portion of our design customers, have been impacted particularly hard. The pandemic has resulted in government authorities and businesses implementing numerous measures to try to contain the virus, such as travel bans and restrictions, quarantines, shelter in place or total lock-down orders, school closures, and business limitations and shutdowns. Such measures have contributed significantly to increased unemployment and negatively impacted consumer and business spending. Business shutdowns have disrupted our supply chain and the manufacture or shipment of our products and delayed the rollout of our retail distribution products. The pandemic has caused us to modify our business practices to help minimize the risk of the virus to our employees, our customers, and the communities in which we participate, which could negatively impact our business. We continue to permit employees to work remotely, which subjects the Company to increased cybersecurity risks and may reduce workplace efficiency. As the availability of vaccines has increased and COVID-19 case rates have diminished, we have gradually begun a phased reopening of our offices. We continue to employ additional safety measures in our offices, including enhanced cleaning and sanitation, mask wearing, suspending international business travel for our employees and limiting domestic business travel, limiting external guests visiting our offices, and holding most meetings and events virtually. Local conditions may require us to move back under more restrictive guidelines, which could include mandatory remote work and additional safety measures. Given the continually evolving situation, there is no certainty that the measures we have taken will be sufficient to mitigate the risks posed by the virus. The full extent to which the COVID-19 pandemic will continue to impact our business, results of operations, and financial condition remains uncertain and will depend on developments that remain uncertain and difficult to predict, including, but not limited to, the duration and spread of the pandemic, its severity, the actions to contain the virus or treat its impact, the availability, distribution and efficacy of vaccines, and acceptance by the population to get the vaccine and how quickly and to what extent normal economic and operating conditions resume. Even after the COVID-19 pandemic has subsided, we may experience material and adverse impacts to our business as a result of the virus’s global economic impact, including the availability of credit, bankruptcies or insolvencies of customers, and recession or economic downturn. 34 Any of the issues discussed above could have a material adverse effect on our business if this continues for an extended period of time. If we incur significant declines in customer orders, increased aging of accounts receivable or other negative consequences due to COVID-19, the extent of which remains highly uncertain, it will have a material adverse effect on our business, financial condition and results of operations. While we attempt to identify, manage, and mitigate risks and uncertainties associated with our business to the extent practical under the circumstances, some level of risk and uncertainty will always be present. Item 1A - “Risk Factors” in the Form 10-K describes some of the risks and uncertainties associated with our business, which we strongly encourage you to review. These risks and uncertainties have the potential to materially affect our business, financial condition, results of operations, cash flows, projected results, and future prospects. There have been no material changes in our risk factors from those disclosed in the Form 10-K. ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS There were no unregistered sales of the Company’s equity securities during the 2021 Quarter that were not previously disclosed in a Current Report on Form 8-K. ITEM 3. DEFAULTS UPON SENIOR SECURITIES None. ITEM 4. MINE SAFETY DISCLOSURES Not Applicable. ITEM 5. OTHER INFORMATION None. ITEM 6. EXHIBITS The exhibits listed in the accompanying “Index to Exhibits” are filed or incorporated by reference as part of this Form 10-Q. 35 Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Dated: August 12, 2021 FORWARD INDUSTRIES, INC. By: /s/ Terence Wise Terence Wise Chief Executive Officer (Principal Executive Officer) By: /s/ Anthony Camarda Anthony Camarda Chief Financial Officer (Principal Financial and Accounting Officer) 36 EXHIBIT INDEX Incorporated by Reference Exhibit No. Exhibit Description Form Date Number Filed or Furnished Herewith 2.1 Stock Purchase Agreement dated January 18, 2018 - Intelligent Product Solutions, Inc.+ 8-K 1/18/18 2.1 2.2 Asset Purchase Agreement by and among Forward Industries, Inc., Kablooe, Inc., Kablooe Design, Inc. and Tom KraMer dated August 17, 2020+ 8-K 8/17/20 2.1 3.1 Restated Certificate of Incorporation 10-K 12/8/10 3(i) 3.2 Certificate of Amendment of the Certificate of Incorporation, April 26, 2013 8-K 4/26/13 3.1 3.3 Certificate of Amendment of the Certificate of Incorporation, June 28, 2013 8-K 7/3/13 3.1 3.4 Third Amended and Restated Bylaws, as of May 28, 2014 10-K 12/10/14 3(ii) 4.1 Promissory Note dated January 18, 2018 – Forward Industries (Asia-Pacific) (as amended and restated) 10-Q 5/13/21 4.1 10.1 Forward Industries, Inc. 2021 Equity Incentive Plan* 8-K 12/23/20 4.1 10.2 Buying Agency and Supply Agreement - Forward Industries (Asia-Pacific) Corporation 10-K 12/16/15 10.7 10.2(a) Amendment No. 1 to Buying Agency and Supply Agreement - Forward Industries (Asia-Pacific) Corporation 10-Q 8/14/17 10.2 10.2(b) Amendment No. 2 to Buying Agency and Supply Agreement - Forward Industries (Asia-Pacific) Corporation 8-K 9/22/17 10.1 10.2(c) Amendment No. 3 to Buying Agency and Supply Agreement – Forward Industries (Asia-Pacific) Corporation 10-Q 5/15/19 10.1(c) 10.2(d) Amendment No. 4 to Buying Agency and Supply Agreement – Forward Industries (Asia-Pacific) Corporation 10-K 12/27/19 10.3(d) 10.2(e) Amendment No. 5 to Buying Agency and Supply Agreement – Forward Industries (Asia-Pacific) Corporation 10-K 12/17/20 10.2(e) 10.3(a) Amended and Restated TD Bank Revolving Term Note dated September 28, 2018 8-K 10/2/18 10.1 10.3(b) TD Bank Modification Agreement dated September 28, 2018 8-K 10/2/18 10.2 31.1 Certification of Principal Executive Officer Filed 31.2 Certification of Principal Financial Officer Filed 32.1 Certification of Principal Executive Officer and Principal Financial Officer Furnished 101.INS Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) 101.SCH Inline XBRL Taxonomy Extension Schema Document 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document 104 Cover Page Interactive Data File (formatted in IXBRL, and included in exhibit 101). + Certain schedules, appendices and exhibits to this agreement have been omitted in accordance with Item 601 of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished supplementally to the Securities and Exchange Commission staff upon request. * Management contract or compensatory plan or arrangement Copies of this filing (including the financial statements) and any of the exhibits referred to above will be furnished at no cost to our shareholders who make a written request to Forward Industries, Inc.; 700 Veterans Memorial Hwy, Suite 100, Hauppauge, NY 11788; Attention: Corporate Secretary. 37